Search for stock quotes, financial statistics and more
Paradigm Capital analyst Scott McAuley is maintaining a “Buy” rating and $2.30 target on... Read More
Paradigm Capital analyst Scott McAuley likes what he sees in clinical stage medical device company S... Read More
Paradigm Capital analyst Scott McAuley shaved a bit off his target price for Spectral Medical (Spect... Read More
The prospects are still good for clinical-stage medical device company Spectral Medical (Spectral Me... Read More
It’s been a long way down over the past year for Spectral Medical (Spectral Medical Stock Quote, C... Read More
Share
Tweet
pin
Share